Guardant Health partners with Nuvalent for cancer diagnostics development
Go back to Guardant Health partners with Nuvalent for cancer diagnostics development| Textainer Group Holdings limited (NASDAQ: GH) | Delayed: 131.78 +2.67 (2.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $129.11 | 52 Week High | $5.84 | |||
| Open | $132.48 | 52 Week Low | $5.49 | |||
| Day High | $134.00 | P/E | N/A | |||
| Day Low | $130.19 | EPS | $0.00 | |||
| Volume | 3,409,025 | |||||
| Nuvel Holdings, Inc. (NASDAQ: NUVL) | Delayed: 123.43 +0.07 (0.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.36 | 52 Week High | $0.40 | |||
| Open | $123.40 | 52 Week Low | $0.14 | |||
| Day High | $123.56 | P/E | N/A | |||
| Day Low | $123.30 | EPS | $-0.56 | |||
| Volume | 4,603,597 | |||||
